These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37858836)

  • 1. Microarray analysis identifies human apoA-I
    Ganzetti GS; Parolini C
    Exp Cell Res; 2023 Dec; 433(1):113826. PubMed ID: 37858836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.
    Parolini C; Chiesa G; Zhu Y; Forte T; Caligari S; Gianazza E; Sacco MG; Sirtori CR; Rubin EM
    J Biol Chem; 2003 Feb; 278(7):4740-6. PubMed ID: 12471038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
    Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
    J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.
    Franceschini G; Calabresi L; Chiesa G; Parolini C; Sirtori CR; Canavesi M; Bernini F
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1257-62. PubMed ID: 10323777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
    J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).
    Chiesa G; Stoltzfus LJ; Michelagnoli S; Bielicki JK; Santi M; Forte TM; Sirtori CR; Franceschini G; Rubin EM
    Atherosclerosis; 1998 Jan; 136(1):139-46. PubMed ID: 9544740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
    Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
    J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Compendium of the Biological Effects of Apolipoprotein A-I
    Parolini C
    J Pharmacol Exp Ther; 2020 Jan; 372(1):54-62. PubMed ID: 31649050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L; Canavesi M; Bernini F; Franceschini G
    Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of native and recombinant apolipoprotein A-IMilano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I.
    Calabresi L; Vecchio G; Longhi R; Gianazza E; Palm G; Wadensten H; Hammarström A; Olsson A; Karlström A; Sejlitz T
    J Biol Chem; 1994 Dec; 269(51):32168-74. PubMed ID: 7798214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice.
    Wang L; Sharifi BG; Pan T; Song L; Yukht A; Shah PK
    J Am Coll Cardiol; 2006 Oct; 48(7):1459-68. PubMed ID: 17010811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
    Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
    J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
    Kalopissis AD; Chambaz J
    Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.